Tag: lab deviations

Deviations, Re-draws & Re-tests: Operating Blueprint for Global GCP-Compliant Studies Deviations, Re-draws & Re-tests: Operating Blueprint for Global GCP-Compliant Studies Introduction to Deviations, Re-draws, and Re-tests in Clinical Trials The execution of clinical trials governed by Good Clinical Practice (GCP) requires meticulous attention to detail, especially concerning deviations, re-draws, and re-tests. These components are critical…

Read More “Deviations, Re-draws & Re-tests: Operating Blueprint for Global GCP-Compliant Studies” »

How to Design Deviations, Re-draws & Re-tests That Meet FDA, EMA and CLIA/CAP Expectations In the realm of clinical trials, particularly prostate cancer clinical trials, the integrity of sample management is of paramount importance. Deviations, re-draws, and re-tests are not just operational nuances; they are critical components that must be meticulously managed to comply with…

Read More “How to Design Deviations, Re-draws & Re-tests That Meets FDA, EMA and CLIA/CAP Expectations” »

Deviations, Re-draws & Re-tests in Practice: Step-by-Step Guide for Sponsors and CROs Deviations, Re-draws & Re-tests in Practice: Step-by-Step Guide for Sponsors and CROs Introduction to Deviations in Clinical Trials In the realm of clinical research informatics, managing deviations, re-draws, and re-tests is a critical component to ensure the integrity of trial data and adherence…

Read More “Deviations, Re-draws & Re-tests in Practice: Step-by-Step Guide for Sponsors and CROs” »

Common Pitfalls in Deviations, Re-draws & Re-tests—and How to Avoid Data and Safety Risks Common Pitfalls in Deviations, Re-draws & Re-tests—and How to Avoid Data and Safety Risks In clinical research, maintaining the integrity of data is of utmost importance. Deviations, re-draws, and re-tests can introduce significant risks to both the data quality and the…

Read More “Common Pitfalls in Deviations, Re-draws & Re-tests—and How to Avoid Data and Safety Risks” »

Aligning Deviations, Re-draws & Re-tests With Protocol, PK/PD and Biomarker Strategies Aligning Deviations, Re-draws & Re-tests With Protocol, PK/PD and Biomarker Strategies Introduction to Clinical Research Management In the realm of clinical research, the precision of data collection, analysis, and compliance is paramount. This includes a robust understanding of protocols and the management of deviations,…

Read More “Aligning Deviations, Re-draws & Re-tests With Protocol, PK/PD and Biomarker Strategies” »